To better understand this, suppose we apply the same diagnostic test (PSA density), using the same cutoff value (≥0.08 ng/mL/cc) to assess the same outcome (clinically significant prostate cancer), but now in a different population. The gene discussed is KLK3; the disease is prostate cancer.